Allele Dmel\Rac1N17.Scer\UAS
| General Information | |||
|---|---|---|---|
| Symbol | Dmel\Rac1N17.Scer\UAS | Species | D. melanogaster |
| Name | FlyBase ID | FBal0038994 | |
| Feature type | allele | Associated gene | Dmel\Rac1 |
| Also Known As | RacN17, DRac1N17 | ||
| Allele class | |||
| Mutagen | in vitro construct - regulatory fusion | ||
Recent Updates
|
|||
| Description |
What does this section display?
This section contains items that were added to this record for each release.
It currently only tracks new links between this FlyBase report and other
FlyBase data classes (e.g. genes, references, stocks) or controlled
vocabulary terms (e.g. GO, anatomy terms).
What does this section not display?
This section does not currently display links that were removed or gene model changes.
|
||
| Update Feed |
Click the icon below to subscribe to this FlyBase record and receive updates automatically through your
feed reader.
|
||
| FB2013_03 | |||
| FB2013_02 |
Controlled Vocabulary Terms
|
||
| All updates | Click here to see a list of all updates to this record from FB2010_08 and on. | ||
Nature of the Allele
| |||
| Allele class | |||
| Mutagen | |||
| Mutations Mapped to the Genome | |||
Type Location Additional Notes References | |||
| Associated Sequence Data | |||
| DDBJ
/
EMBL / GenBank | DNA sequence Protein sequence Name | ||
| UniProtKB/Swiss-Prot | |||
| UniProtKB/TrEMBL | |||
| Progenitor genotype | |||
| Nature of the lesion | Statement Reference | ||
| Carried in construct | (Silver et al., 2005, Barrett et al., 1997, Sanchez-Soriano and Prokop, 2005, Fernandes et al., 2005, Silver, 2005, Medioni and Noselli, 2005, Bashaw et al., 2001, Hu et al., 2001, Kaufmann et al., 1998, Sepp and Auld, 2003, Prokopenko et al., 1999, Woolner et al., 2005, Raymond et al., 2001, Lee and Kolodziej, 2002, Hu et al., 2005, Hacker and Perrimon, 1998, Suzanne et al., 2001, Duchek et al., 2001, Jones and Bejsovec, 2005, Harden et al., 2002, Magie et al., 2002, Simoes et al., 2006, Lawrence et al., 2002, Fritz and VanBerkum, 2002, Kunwar et al., 2003, Geisbrecht and Montell, 2004, Geisbrecht and Montell, 2002, Dutta et al., 2004, Fan et al., 2003, Strutt et al., 2002, Fanto et al., 2000, Fanto, 2000, Chang and Ready, 2000, Luo et al., 1994, Benlali et al., 2000, Bateman et al., 2000, Martin-Bermudo et al., 1999, Paululat et al., 1999, Harden et al., 1999, Ricos et al., 1999, Olofsson and Page, 2005, Sotillos and Campuzano, 2000, Zettervall et al., 2004, Albin and Davis, 2004, Emoto et al., 2004, Murphy and Montell, 1996, Eaton et al., 1995, Dobens et al., 2001, Kim et al., 2003, Hou et al., 1997, Eaton et al., 1996, Long et al., 2006, Huelsmann et al., 2006, Stramer et al., 2005, Hozumi et al., 2006, Srahna et al., 2006, Geisbrecht et al., 2008, Pirraglia et al., 2006, Leiss et al., 2009, Korolchuk et al., 2007, Allen et al., 2000, Wang et al., 2010, Wang et al., 2010, Paladi and Tepass, 2004, Garlena et al., 2010, Sato et al., 2010, Assaker et al., 2010, Song and Giniger, 2011, Shuai et al., 2011, Kuzina et al., 2011, van Impel et al., 2009, Renault et al., 2010, Kim et al., 2010, Morris et al., 2012, Elsaesser et al., 2010, Raymond et al., 2004, Tsubouchi et al., 2012) | ||
| Cytology | |||
Phenotypic Data
| |||
Phenotypic Class
| |||
Phenotype Manifest In
| |||
axon & dorsal cluster neuron, with Scer\GAL4ato.3.6 dendritic spine & lobular plate tangential neuron, with Scer\GAL4DB331 embryonic leading edge cell & actin filament, with Scer\GAL4en-e16E microchaeta & wing, with Scer\GAL4ptc-559.1 rhabdomere & actin filament, with Scer\GAL4unspecified rhabdomere & microvillus, with Scer\GAL4unspecified | |||
Detailed Description
| |||
Statement Reference Class III ddaA neurons expressing Rac1[N17.Scer\UAS] under the control of Scer\GAL4[1003.3] show a significant decrease in the number of dendritic sensory filopodia compared to wild type. The average length of the filopodia is significantly decreased compared to wild type, while the total length of primary dendritic branches is not altered.
Larvae expressing Rac1[N17.Scer\UAS] under the control of Scer\GAL4[1003.3] show a reduced response to gentle touch compared to controls. Flies with induced expression of Rac1[N17.Scer\UAS] for three days under the control of Scer\GAL4[elav-C155] and Scer\GAL80[ts.αTub84B] show a remarkable tolerance to paraquat-induced oxidative stress, desiccation, starvation and high temperature. These flies survive for 50-100% longer than control flies in adverse conditions.
The body weight of flies expressing of Rac1[N17.Scer\UAS] for three days under the control of Scer\GAL4[elav-C155] and Scer\GAL80[ts.αTub84B] is largely comparable to un-induced controls, although a marginal but statistically significant increase is found in males. The level of triglyceride, the primary storage form of lipid, is not altered either. The fecundity of female flies as determined by the number of eggs laid per fly per day is not compromised compared to that of controls.
Continuous expression of Rac1[N17.Scer\UAS] under the control of Scer\GAL4[elav-C155] and Scer\GAL80[ts.αTub84B] (with flies kept at 30[o]C) does not confer any obvious beneficial or detrimental effects on life span.
Flies with induced expression of Rac1[N17.Scer\UAS] for three days under the control of Scer\GAL4[Cha.7.4] and Scer\GAL80[ts.αTub84B] exhibit improved survival rates compared to controls when exposed to 20 mM paraquat and desiccation.
Flies with induced expression of Rac1[N17.Scer\UAS] for three days under the control of Scer\GAL4[repo] and Scer\GAL80[ts.αTub84B] do not exhibit improved survival rates compared to controls when exposed to 20 mM paraquat and desiccation. Expression of Rac1[N17.Scer\UAS] under the control of Scer\GAL4[60] results in a low frequency of axonal 'stalling' phenotypes. Hindgut epithelial cells do not show the left-right asymmetry in cell shape which is seen in wild-type hindgut epithelial cells at late stage 12 (before epithelial tube rotation) in embryos expressing Rac1[N17.Scer\UAS] under the control of Scer\GAL4[NP2432]. Expression of Rac1[N17.Scer\UAS] driven by Scer\GAL4[slbo.2.6] results in the impairment of border cell migration during egg chamber development. Expression of Rac1[N17.Scer\UAS] under the control of Scer\GAL4[nos.UTR.T:Hsim\VP16] does not block germ cell transepithelial migration or later germ cell migration. Expression of Rac1[N17.Scer\UAS] under the control of Scer\GAL4[DB331] does not alter the overall dendritic architecture in the lobular plate tangential cells; neither the position not branching patterns of primary and secondary order dendrites are affected. However, there is an increase in spine density and a change in spine morphology (the spines appear shorter and less well defined) compared to controls. Scer\GAL4[GMR.PU]-mediated expression of Rac1[N17.Scer\UAS] results in a severe rough eye. Expression of Rac1N17.Scer\UAS under the control of Scer\GAL4GMR.PF results in a weak axonal hyperfasciculation phenotype in the lamina and medulla. The salivary gland fails to migrate posteriorly and some cells remain at the ventral surface in embryos expressing Rac1[N17.Scer\UAS] under the control of Scer\GAL4[fkh.PH]. Expression of Rac1N17.Scer\UAS under the control of cer\GAL4ato.3.6 results in a marked increase in the number of axons from dorsal cluster neurons crossing the optic chiasm (an average of only 19.8 axons crossing in contrast to the wild-type average of 11.7). Expression of Rac1N17.Scer\UAS in myoblasts, driven by Scer\GAL41151, affects indirect flight muscles. There is a reduction in the mean number of dorsal longitudinal muscle (DLM) fibers (from 6 to ~4) and in DLM size (35% reduction in area). Additionally, the tergal depressor of trochanter (TDT) and the dorso-ventral muscles (DVMs) are almost completely absent. Expression of Rac1N17.Scer\UAS, under the control of Scer\GAL41151, does not affect the number of adult muscle precursors present at late embryonic stages. However, there is an approximately 43% reduction in the number of myoblast numbers in the wing discs of third instar larva. Experiments using Scer\GAL80ts.αTub84B show that Rac1N17.Scer\UAS needs to be expressed during larval stages to affect muscle development. Expression of Rac1N17.Scer\UAS, under the control of Scer\GAL41151, affects pupal myogenesis. DLM myoblast expansion and proliferation follows a different pattern in Scer\GAL41151/+; Rac1N17.Scer\UAS/+ mutants compared to controls: in the mutants there is no significant increase of proliferation at 12-16 hours APF and there is a sharp decline in expanse by 20 hours APF. At 16 hours APF, Scer\GAL41151/+; Rac1N17.Scer\UAS/+ myoblasts undergo less fusion than controls. Fiber formation is delayed compared to controls, and by 24 hours APF, the majority of Scer\GAL41151/+; Rac1N17.Scer\UAS/+ mutants have only 3 DLM fibers, instead of the wild-type number of 6. Pupal myogenesis is severely affected in the DVMs of Scer\GAL41151/+; Rac1N17.Scer\UAS/+ mutants. Myoblast proliferation fails to increase at 12-16 hours APF and there is a sharp decline at 20 hours APF. At 16 hours APF, Scer\GAL41151/+; Rac1N17.Scer\UAS/+ DVM myoblasts are disorganized and are not aligned along the long axis of the founder cells, as occurs in wild type. At 20-24 hours APF, control myoblasts become compact and rounded, while Scer\GAL41151/+; Rac1N17.Scer\UAS/+ DVM myoblasts fail to assume this shape. Myoblast segregation and fusion does not occur in the mutants. By 20 hours APF, when DVM fiber formation is complete in controls, myoblasts of Scer\GAL41151/+; Rac1N17.Scer\UAS/+ mutants remain unpatterned. When Rac1N17.Scer\UAS is driven by Scer\GAL4elav.PLu, embryos display mild midline axon outgrowth defects, with small breaks in the outermost longitudinal pathways, with rare axons ectopically crossing the midline. Expression of Rac1N17.Scer\UAS under the control of Scer\GAL4arm.PS does not affect ventral patterning in the embryo, but causes a dorsal hole phenotype. Expression of Rac1N17.Scer\UAS in border cells, driven by Scer\GAL4slbo.2.6, inhibits the migration of border cell clusters to the oocyte. However, the apical cap of these egg chambers forms and is shed normally. Expression of Rac1N17.Scer\UAS, under the control of the hemocyte-specific driver Scer\GAL4crq.PO, inhibits hemocyte migration in the embryo by stage 14. Hemocytes begin migration out of the head region, but then lose polarized migration and accumulate in the anterior of the embryo. At stage 17, the ventral nerve cord is shorter in Rac1N17.Scer\UAS embryos than in wild-type, indicating that the VNC fails to condense correctly in Rac1N17.Scer\UAS mutants. Expression of Rac1N17.Scer\UAS in the lateral glia, driven by Scer\GAL4158, results in inhibition of VNC condensation in embryos but does not affect the differentiation or survival of the lateral glial cells. Expression of Rac1N17.Scer\UAS throughout the CNS, driven by Scer\GAL4elav-C155, does not affect the condensation of the VNC in embryos. Expression of Rac1N17.Scer\UAS in the aCC/RP2 axons (under the control of Scer\GAL4eve.RN2), results in stalling in 15.2% of hemisegments. Stalled aCC/RP2 axons cause a co-arrest of the complete intersegmental motor nerve in 90% of cases. Expression of Rac1N17.Scer\UAS, under the control of Scer\GAL4slbo.2.6, inhibits border cell migration. Developmental dispersal of hemocytes is abnormal in embryos expressing Rac1N17.Scer\UAS under the simultaneous control of both Scer\GAL4Pxn.PS and Scer\GAL4crq.PA.
One hour after laser-induced wounding, approximately half the number of hemocytes are recruited to the wound in embryos expressing Rac1N17.Scer\UAS under the simultaneous control of both Scer\GAL4Pxn.PS and Scer\GAL4crq.PA compared to wild type embryos. Hemocytes that are recruited in the mutant embryos have significantly reduced lamellar protrusions. Expression of Rac1N17.Scer\UAS in segmental stripes of the embryonic epithelium, driven by Scer\GAL4en-e16E, inhibits the production of actin protrusions and the actin cable within epithelial cells. These embryos are able to complete dorsal closure but the Rac1N17.Scer\UAS-expressing cells fail to fuse properly, which results in the presence of small holes in the midline. These embryos also show segmental mismatching along the midline. Expression of Rac1N17.Scer\UAS in the muscle, under the regulation of Scer\GAL4Mhc.PW has no effect on synapse development. Rac1N17.Scer\UAS; Scer\GAL41151 pupae have severely reduced myoblast fusion, the effect being most dramatic in the lateral muscles of the abdomen and, to a lesser extent, in the thoracic muscles. The lateral muscles of the abdomen in these pupae don't fuse and the resulting unfused myoblasts cluster around founder myoblasts, but do not differentiate further. Each unfused founder cell elongates and differentiates into a thin myotube eventually eventually developing into a mononucleate fibre. By contrast, some fusion does occur in the developing dorso-ventral indirect flight muscles. The putative founders myoblasts of these muscles are present in the pupal thorax in a wild-type pattern. These founders initiate fibre formation, but to a lesser extent than normal, leading to the formation of fibres with fewer nuclei than wild-type fibres of the same stage. The resulting muscles are abnormally thin, but form at the correct position and with the correct number of fibres. When Rac1N17.Scer\UAS is driven by Scer\GAL4477, no detectable phenotype is seen in dendrites. Expression of Rac1N17.Scer\UAS under the control of Scer\GAL4slbo.2.6 results in defects in border follicle cell migration in more than 95% of stage 10 egg chambers. Expression of Rac1N17.Scer\UAS under the control of Scer\GAL4slbo.2.6 does not results in apoptotic cells in stage 10 egg chambers. Expression of Rac1N17.Scer\UAS under the control of Scer\GAL469B or Scer\GAL4pnr-MD237 results in a failure of dorsal closure and lethality. Expression of Rac1N17.Scer\UAS under the control of Scer\GAL4how-24B results in dramatic defects in myoblast fusion. Expression of Rac1[N17.Scer\UAS] under the control of Scer\GAL4[gcm-rA87.P] blocks macrophage migration in embryos; only a few macrophages move anteriorly and posteriorly for short distances.
Expression of Rac1[N17.Scer\UAS] under the control of Scer\GAL4[Cg25C-A109.1F2.P] causes macrophages to clump in various areas of the embryo (such as the head region, around the pharynx, midgut and hindgut and laterally along the ventral cord). This defect is seen at stage 16, but becomes more pronounced during stage 17. The macrophages are abnormal in shape in the mutant embryos, appearing rounder than normal due to a block in the formation of cellular protrusions.
Macrophages expressing Rac1[N17.Scer\UAS] under the control of Scer\GAL4[unspecified] show wild-type levels of cortical F-actin. The macrophages have few or no cytoplasmic extensions in the mutant embryos. Flies expressing Rac1[N17.Scer\UAS] under the control of Scer\GAL4[GMR.PU] have rough eyes with a loss of rhabdomeres, abnormal photoreceptor cells, vacuolated material in the retina and polarity defects. When expression is driven by Scer\GAL4He.PZ, hemocyte proliferation is unaffected, lamellocytes are abnormal and replaced by multinucleate cells that do not express lamellocyte markers and crystal cells are decreased. Rac1N17.Scer\UAS; Scer\GAL4btl.PS embryos have tracheal defects including truncated and/or zig-zagged dorsal trunk, misguided dorsal branches and a lack of terminal branches. The cell rearrangements occurring during extension of the dorsal branches towards the dorsal midline are greatly inhibited in these embryos: migration of cells to form the dorsal branch begins, but the number of cells contributed is less than in wild-type, and the resulting dorsal branches are shorter, occasionally failing to form at all. When Rac1N17.Scer\UAS is overexpressed under the control of Scer\GAL4elav.PLu, mutants do not exhibit longitudinal axon ectopic midline crossing defects. Although Rac1N17.Scer\UAS; Scer\GAL4elav.PLu embryos have occasional defects in the segmental nerve (SN)b and SNa motoneurons, they always extend their axons out of the CNS (as part of the abdominal posterior fascicle). In some cases (16%), the lateral branch of SNa motor axon actually extends beyond its target muscles. Rac1N17.Scer\UAS driven by Scer\GAL4GMR.PF gives a rough eye phenotype. When Rac1N17.Scer\UAS is driven by Scer\GAL4repo, mutant embryos have mildly disrupted glial wrapping profiles with occasional small gaps in the nerve sheath. Sensory neurons also show defasciculation. When Rac1N17.Scer\UAS is driven by Scer\GAL4ftz.ng, no midline crossovers are seen in the pCC/MP2 pathway axons. When Rac1N17.Scer\UAS is driven by Scer\GAL4elav.PLu, no adults eclose. Expression of Rac1N17.Scer\UAS, driven by Scer\GAL4332.3, causes a failure to secrete cuticle in 61% of embryos and holes in the dorsal surface of 8% of embryos that do manage cuticle secretion. Expression of Rac1N17.Scer\UAS, driven by Scer\GAL4332.3, results in impairment of amnioserosa morphogenesis and migration of the epidermis. The amnioserosa of these mutants remains elliptical at an age where the same tissue is narrowing in wild type. This lack of morphological change appears to impede the movement of the epidermis resulting in a dorsal hole which is larger than in wild type. Within a single mutant embryo there may be patches of cells that change shape correctly and patches that do not. The progression of the epidermis is impeded more around patches of cells that have failed to change shape. Overexpression of Rac1N17.Scer\UAS driven by Scer\GAL4c381 does not cause failure of cuticle formation. However, embryos do fail to complete dorsal closure and have a large dorsal hole in the cuticle extending from the middle of the dorsal surface to the rear of the embryo. Additionally, the epidermis fails to migrate over the amnioserosa. Expression of Rac1N17.Scer\UAS under the control of Scer\GAL4btl.PS does not affect lumen formation in the tracheal system although these embryos do show some defects in tracheal branch migration. 77.6% of ommatidia in mutant somatic clones (driven by Scer\GAL4hs.2sev) in the eye are normal. 18.1% have rotated ommatidia, 0.5% have chirality defects, 0.7% are achiral (3.1% unscorable). Co-expression of Rac1N17.Scer\UAS has little or no effect on the gain of function axon guidance defects caused by expression of Gef64CEP3035 under the control of Scer\GAL4elav.PLu. Clones of cells expressing Rac1N17.Scer\UAS under the control of Scer\GAL4Act5C.PP in the nurse cell follicle cells results in aberrant morphology. When Rac1N17.Scer\UAS is driven by Scer\GAL4elav.PLu dramatic effects are seen on axon guidance. The intersegmental nerve b (ISNb) fails to branch off and enter the ventral muscles and instead follows the ISN distally toward dorsal muscles. The SNa motor axons also sometimes abnormally project to lateral muscle targets, bypassing their normal targets. Embryos expressing Rac1N17.Scer\UAS under the control of Scer\GAL4ptc-559.1 have a dorsal hole. Eggs derived from females expressing Rac1N17.Scer\UAS under the control of Scer\GAL4T155 have short dorsal appendages. Eggs derived from females expressing Rac1N17.Scer\UAS under the control of Scer\GAL4CY2 show a failure of the dorsal appendages to elongate. Approximately 70% of axons expressing Rac1[N17.Scer\UAS] under the control of Scer\GAL4[A307] exhibit morphological abnormalities such as excess branching in the target region. The axons often send ectopic projections across the midline into the contralateral side of the ganglion in T2 or extra processes down into T3, a phenotype never seen in controls. In some cases one GF splits and makes bilateral bends while its partner grows on into T3 without making any bend. Often the axons split several times sending a number of projections to inappropriate parts of the ganglion. In addition to these extra processes the lateral bends, along which the synapse with the TTMn can be formed, are always seen in T2.
The function of the GF-TTMn synapse in Scer\GAL4[A307]; Rac1[N17.Scer\UAS] flies in both the response latency and the percentage following at 250Hz are normal.
Dendritic defects are seen in about 25% of Scer\GAL4[A307]; Rac1[N17.Scer\UAS] GFs. The dendritic field always contains its distinct domains, but the large dendrites have a brush-like appearance with many small processes emanating from the larger ones.
Approximately 81% of Scer\GAL4[A307]; Rac1[Scer\UAS.cLa] flies exhibit a bendless GF phenotype, while 64% of Scer\GAL4[A307]; Rac1[Scer\UAS.cLa] GFs are bendless. The remainder exhibit wild-type bends or large abnormally shaped processes in the target region. When expression is driven by Scer\GAL4elav-C155, ISNb shows a bypass phenotype. The CNS shows similar breaks in longitudinal connectives to those of trio loss of function mutants. Expression of Rac1N17.Scer\UAS under the control of Scer\GAL4ey.PH results in uncoordinated differentiation in the eye disc. Expression of Rac1N17.Scer\UAS under the control of Scer\GAL4unspecified during rhabdomere morphogenesis results in reduced, disorganised rhabdomeres. Fewer microvilli than normal are seen in cross section and a well-defined rhabdomere base is not formed; apposed sheets of membrane are involuted into the photoreceptor cytoplasm. The actin cytoskeleton appears diffuse and disordered. Rac1N17.Scer\UAS when driven by Scer\GAL4hs.2sev leads to planar polarity, defects in the eye. This phenotype is enhanced by the addition of Df(3L)Ar14-8, which removes the Rac1 gene. Although it is mostly ommatidial rotation that is randomised in Scer\GAL4hs.2sev, Rac1N17.Scer\UAS mutants the enhancement of the phenotype by Df(3L)Ar14-8 increases the number of symmetrical, achiral ommatidia. These phenotypes appear early in development, suggesting they are primary defects. When expression is driven by Scer\GAL4sd-SG29.1 wing size is reduced. Embryos expressing Rac1N17.Scer\UAS under the control of Scer\GAL4ptc-559.1 or Scer\GAL4hs.PB (using heat shock) have dorsal holes ranging in size from a small 'scab' to a wide open dorsal surface. Expression of Rac1N17.Scer\UAS under the control of Scer\GAL448Y in the developing midgut causes a delay in migration of the endodermal midgut cells. Expression of Rac1N17.Scer\UAS by Scer\GAL4prd.RG1 has no effect on cytokinesis or mitosis. Scer\GAL4twi.PG-mediated expression causes severe cuticle defects. Scer\GAL4elav-C155-mediated expression causes ISNb axons to extend past the ventral longitudinal muscles. ISNb axons may also form a distinct fascicle that follows the ISN beyond ventral muscles. Phenotype of segments showing any evidence of ISNb bypass or the full bypass phenotype is more severe with Scer\GAL41407 or Scer\GAL4elav.PLu-mediated expression. Scer\GAL4elav-C155-mediated expression causes the dorsal projection of SNa axons to extend beyond the distal edge of muscle 4 or the axons extend beyond the target site to make ectopic contacts onto dorsal muscles, sensory sheath cells or ISN axons. Phenotype is more severe with Scer\GAL41407 or Scer\GAL4elav.PLu-mediated expression. Scer\GAL4elav-C155-mediated expression causes defects in the morphology of the CNS pathways. Coexpression of Rac1Scer\UAS.cLa under the same Scer\GAL4 driver yields near normal morphology of the CNS pathways, some abnormalities can be seen in occasional segments. Embryos exhibit a dorsal open phenotype. Causes duplications and triplications of wing hairs when expressed using Scer\GAL4ptc-559.1. The duplicated or triplicated hairs are morphologically indistinguishable from wild-type. Actin distribution in Rac1N17.Scer\UAS expressing cells is abnormal at 30-35 hours after puparium formation, and microtubules appear disorganised 30-32 hours after puparium formation. Scer\GAL4198Y- or Scer\GAL4306-mediated expression causes no or little border cell migration in 80% stage 10 egg chambers. 19 to 22% of laid eggs hatch. Scer\GAL4458-mediated expression causes arrested migration in 10% of stage 10 egg chambers. Removing Rac1 activity during migration (using Scer\GAL4hs.PB) seems to halt all activity. Wing discs expressing Rac1N17.Scer\UAS using Scer\GAL4ptc-559.1 often contain dead cells that are extruded from the basal side of the epithelium. Adherens junction actin is disrupted in cells expressing Rac1N17.Scer\UAS. Wings derived from discs in which Rac1N17.Scer\UAS is expressed using Scer\GAL4ptc-559.1 are of normal length but narrow, with the reduction in wing area restricted to the anterior compartment. Wing hairs are often duplicated or triplicated, the penetrance of this phenotype decreasing at the wing margin. Semi-embryonic lethal with Scer\GAL41407 and Scer\GAL4elav.PLu and viable with Scer\GAL460. Embryos with Scer\GAL4how-24B have weak muscle contractions. | |||
External Data
| |||
| Linkouts | |||
Interactions
| |||
|
|||
Phenotypic Class
| |||
Enhanced by | |||
Statement Reference Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has neuroanatomy defective phenotype, enhanceable by bure10/bur[+] Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, enhanceable by CG7231EP2510, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, enhanceable by dcoEP3280, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, enhanceable by Dsp1EP355, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, enhanceable by Eip78CEP3468, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, enhanceable by EP1207EP1207, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, enhanceable by EP1408EP1408, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, enhanceable by lilliEP1211, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, enhanceable by tlkEP1413, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, enhanceable by touEP622, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has visible phenotype, enhanceable by C3GScer\UAS.T:Hsap\MYC, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has visible phenotype, enhanceable by CG5261EP816, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has visible phenotype, enhanceable by CG6701EP2054, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has visible phenotype, enhanceable by P{EP}EP2233, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has visible phenotype, enhanceable by P{EP}EP2491, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has visible phenotype, enhanceable by SNF4AγEP648, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4sd-SG29.1 has visible phenotype, enhanceable by tumScer\UAS.cSa, Scer\GAL4sd-SG29.1 | |||
NOT Enhanced by | |||
Statement Reference Rac1N17.Scer\UAS, Scer\GAL4ato.3.6 has neuroanatomy defective phenotype, non-enhanceable by btlScer\UAS.cDa, Scer\GAL4ato.3.6 Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-enhanceable by agoEP1135, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-enhanceable by AmunEP1503, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-enhanceable by Atg1EP3348, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-enhanceable by ballEP863, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-enhanceable by CG1090EP3028, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-enhanceable by CG3542EP719, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-enhanceable by CG4266EP2258, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-enhanceable by CG10082EP436, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-enhanceable by CG10082EP2310, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-enhanceable by CG10082EP2440, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-enhanceable by CG10433EP2034, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-enhanceable by CG10433EP2516, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-enhanceable by CHES-1-likeEP1342, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-enhanceable by CHES-1-likeEP1453, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-enhanceable by Dlc90FEP3634, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-enhanceable by EP712EP712, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-enhanceable by EP1200EP1200, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-enhanceable by EP1340EP1340, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-enhanceable by EP2444EP2444, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-enhanceable by HmgDEP467, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-enhanceable by leaEP2582, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-enhanceable by MESR4EP988, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-enhanceable by NFATEP1335, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-enhanceable by NFATEP1353, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-enhanceable by NFATEP1390, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-enhanceable by NFATEP1508, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-enhanceable by Sar1EP3575, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-enhanceable by skdEP3443, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-enhanceable by Smg5EP2171, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-enhanceable by TaoEP1455, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-enhanceable by Tim10EP541, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-enhanceable by Tim10EP2421, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-enhanceable by Tsp42EfEP2571, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by Akap200EP2072, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by CG2017EP3503, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by cindrEP3700, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by domEP2371, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by Dp1EP2422, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by EP474EP474, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by hppyEP2445, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by kisEP563, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by MESR4EP386, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by P{EP}faxEP807, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by P{EP}wunEP652, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by rho-6EP2023, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by RhoGEF64CEP3035, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has visible phenotype, non-enhanceable by Traf6EP325, Scer\GAL4GMR.PU | |||
Suppressed by | |||
Statement Reference Rac1N17.Scer\UAS, Scer\GAL469B has lethal | embryonic stage phenotype, suppressible | partially by thScer\UAS.T:Ivir\HA1, Scer\GAL469B Rac1N17.Scer\UAS, Scer\GAL4ato.3.6 has neuroanatomy defective phenotype, suppressible by bskDN.Scer\UAS, Scer\GAL4ato.3.6 Rac1N17.Scer\UAS, Scer\GAL4elav.PLu, sli2 has neuroanatomy defective phenotype, suppressible | partially by PakScer\UAS.T:Myr-Src64B, Scer\GAL4elav.PLu Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, suppressible by CG10082EP2319, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, suppressible by EP2204EP2204, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has visible phenotype, suppressible by numbEP2455, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4pnr-MD237 has lethal | embryonic stage phenotype, suppressible | partially by thScer\UAS.T:Ivir\HA1, Scer\GAL4pnr-MD237 | |||
NOT suppressed by | |||
Statement Reference Rac1N17.Scer\UAS, Scer\GAL4ato.3.6 has neuroanatomy defective phenotype, non-suppressible by btlScer\UAS.cDa, Scer\GAL4ato.3.6 Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-suppressible by agoEP1135, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-suppressible by AmunEP1503, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-suppressible by Atg1EP3348, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-suppressible by ballEP863, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-suppressible by CG1090EP3028, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-suppressible by CG3542EP719, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-suppressible by CG4266EP2258, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-suppressible by CG10082EP436, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-suppressible by CG10082EP2310, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-suppressible by CG10082EP2440, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-suppressible by CG10433EP2034, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-suppressible by CG10433EP2516, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-suppressible by CHES-1-likeEP1342, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-suppressible by CHES-1-likeEP1453, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-suppressible by Dlc90FEP3634, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-suppressible by EP712EP712, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-suppressible by EP1200EP1200, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-suppressible by EP1340EP1340, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-suppressible by EP2444EP2444, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-suppressible by HmgDEP467, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-suppressible by leaEP2582, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-suppressible by MESR4EP988, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-suppressible by NFATEP1335, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-suppressible by NFATEP1353, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-suppressible by NFATEP1390, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-suppressible by NFATEP1508, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-suppressible by Sar1EP3575, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-suppressible by skdEP3443, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-suppressible by Smg5EP2171, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-suppressible by TaoEP1455, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-suppressible by Tim10EP541, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-suppressible by Tim10EP2421, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has visible phenotype, non-suppressible by Tsp42EfEP2571, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by Akap200EP2072, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by CG2017EP3503, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by cindrEP3700, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by domEP2371, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by Dp1EP2422, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by EP474EP474, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by hppyEP2445, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by kisEP563, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by MESR4EP386, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by P{EP}faxEP807, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by P{EP}wunEP652, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by rho-6EP2023, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by RhoGEF64CEP3035, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has visible phenotype, non-suppressible by Traf6EP325, Scer\GAL4GMR.PU | |||
Enhancer of | |||
Statement Reference Scer\GAL460/Rac1N17.Scer\UAS is an enhancer of neuroanatomy defective | heat sensitive phenotype of Nl1N-ts1 Scer\GAL4twi.2PE/Rac1N17.Scer\UAS is an enhancer of cell migration defective | embryonic stage phenotype of pbl5 | |||
NOT Enhancer of | |||
Statement Reference Rac1N17.Scer\UAS, Scer\GAL4ato.3.6 is a non-enhancer of neuroanatomy defective phenotype of Scer\GAL4ato.3.6, bskDN.Scer\UAS | |||
Suppressor of | |||
Statement Reference Rac1N17.Scer\UAS, Scer\GAL4ato.3.6 is a suppressor of neuroanatomy defective phenotype of Scer\GAL4ato.3.6, btlScer\UAS.cDa Rac1N17.Scer\UAS/Scer\GAL4C57 is a suppressor of neuroanatomy defective | larval stage phenotype of Vps35EY14200/Df(2R)ED3952 Rac1N17.Scer\UAS/Scer\GAL4elav.PLu is a suppressor of neuroanatomy defective | larval stage phenotype of Vps35EY14200/Df(2R)ED3952 Scer\GAL415J2/Rac1N17.Scer\UAS is a suppressor of neuroanatomy defective | recessive phenotype of Nl1N-ts1 | |||
NOT Suppressor of | |||
Statement Reference Rac1N17.Scer\UAS, Scer\GAL4ato.3.6 is a non-suppressor of neuroanatomy defective phenotype of Scer\GAL4ato.3.6, bskDN.Scer\UAS Scer\GAL4nos.UTR.T:Hsim\VP16/Rac1N17.Scer\UAS is a non-suppressor of decreased cell number | germline clone | maternal effect | embryonic stage 15 phenotype of wun2EP2650ex34, wun49 Scer\GAL4nos.UTR.T:Hsim\VP16/Rac1N17.Scer\UAS is a non-suppressor of decreased cell number | germline clone | maternal effect | embryonic stage 16 phenotype of wun2EP2650ex34, wun49 Scer\GAL4nos.UTR.T:Hsim\VP16/Rac1N17.Scer\UAS is a non-suppressor of increased cell death | germline clone | maternal effect | embryonic stage phenotype of wun2EP2650ex34, wun49 Scer\GAL4NP2225/Rac1N17.Scer\UAS is a non-suppressor of neuroanatomy defective | embryonic stage phenotype of cv-c1260 | |||
Other | |||
Statement Reference | |||
Phenotype Manifest In
| |||
Enhanced by | |||
Statement Reference Rac1N17.Scer\UAS, Scer\GAL4elav.PLu has abdominal segmental nerve phenotype, enhanceable by plexBScer\UAS.cHa, Scer\GAL4elav.PLu Rac1N17.Scer\UAS, Scer\GAL4elav.PLu has intersegmental nerve phenotype, enhanceable by plexBScer\UAS.cHa, Scer\GAL4elav.PLu Rac1N17.Scer\UAS, Scer\GAL4elav.PLu has medial longitudinal fascicle phenotype, enhanceable by RhoGAP93BScer\UAS.cHa, Scer\GAL4elav.PLu Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has lamina phenotype, enhanceable by bure10/bur[+] Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has medulla phenotype, enhanceable by bure10/bur[+] Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has eye phenotype, enhanceable by C3GScer\UAS.T:Hsap\MYC, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4sd-SG29.1 has wing phenotype, enhanceable by tumScer\UAS.cSa, Scer\GAL4sd-SG29.1 Rac1N17.Scer\UAS, Scer\GAL4slbo.2.6 has border follicle cell phenotype, enhanceable by Rab11S25N.Scer\UAS.P\T.T:Avic\GFP-YFP, Scer\GAL4slbo.2.6 | |||
NOT Enhanced by | |||
Statement Reference Rac1N17.Scer\UAS, Scer\GAL4ato.3.6 has axon & dorsal cluster neuron phenotype, non-enhanceable by btlScer\UAS.cDa, Scer\GAL4ato.3.6 Rac1N17.Scer\UAS, Scer\GAL4ato.3.6 has axon & dorsal cluster neuron phenotype, non-enhanceable by dsh1 Rac1N17.Scer\UAS, Scer\GAL4elav.PLu has abdominal segmental nerve phenotype, non-enhanceable by plexBBd7.Scer\UAS, Scer\GAL4elav.PLu Rac1N17.Scer\UAS, Scer\GAL4elav.PLu has intersegmental nerve phenotype, non-enhanceable by plexBBd7.Scer\UAS, Scer\GAL4elav.PLu Rac1N17.Scer\UAS, Scer\GAL4elav.PLu has medial longitudinal fascicle phenotype, non-enhanceable by Cdc42N17.Scer\UAS, Scer\GAL4elav.PLu Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has eye phenotype, non-enhanceable by Sra-1EP3267, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has eye phenotype, non-enhanceable by Sra-1unspecified Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has ommatidium phenotype, non-enhanceable by Sra-1EP3267, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has ommatidium phenotype, non-enhanceable by Sra-1unspecified Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has eye phenotype, non-enhanceable by Akap200EP2072, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has eye phenotype, non-enhanceable by CG2017EP3503, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has eye phenotype, non-enhanceable by cindrEP3700, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has eye phenotype, non-enhanceable by P{EP}faxEP807, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has eye phenotype, non-enhanceable by P{EP}wunEP652, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has eye phenotype, non-enhanceable by rho-6EP2023, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has eye phenotype, non-enhanceable by RhoGEF64CEP3035, Scer\GAL4GMR.PU | |||
Suppressed by | |||
Statement Reference Rac1N17.Scer\UAS, Scer\GAL469B has dorsal closure embryo phenotype, suppressible by thScer\UAS.T:Ivir\HA1, Scer\GAL469B Rac1N17.Scer\UAS, Scer\GAL469B has embryonic/first instar larval cuticle | dorsal phenotype, suppressible by thScer\UAS.T:Ivir\HA1, Scer\GAL469B Rac1N17.Scer\UAS, Scer\GAL4ato.3.6 has axon & dorsal cluster neuron phenotype, suppressible by bskDN.Scer\UAS, Scer\GAL4ato.3.6 Rac1N17.Scer\UAS, Scer\GAL4elav.PLu, sli2 has longitudinal connective phenotype, suppressible | partially by PakScer\UAS.T:Myr-Src64B, Scer\GAL4elav.PLu Rac1N17.Scer\UAS, Scer\GAL4elav.PLu has intersegmental nerve phenotype, suppressible | partially by plexBdsRNA.cHa Rac1N17.Scer\UAS, Scer\GAL4elav-C155 has intersegmental nerve phenotype, suppressible by trioScer\UAS.cBa, Scer\GAL4elav-C155 Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has eye phenotype, suppressible by mbcScer\UAS.cBa/Ced-12Scer\UAS.cGa, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4hs.PB has dorsal closure embryo phenotype, suppressible | partially by tkvTAJ3 Rac1N17.Scer\UAS, Scer\GAL4pnr-MD237 has dorsal closure embryo phenotype, suppressible by thScer\UAS.T:Ivir\HA1, Scer\GAL4pnr-MD237 Rac1N17.Scer\UAS, Scer\GAL4pnr-MD237 has embryonic/first instar larval cuticle | dorsal phenotype, suppressible by thScer\UAS.T:Ivir\HA1, Scer\GAL4pnr-MD237 Rac1N17.Scer\UAS, Scer\GAL4slbo.2.6 has border follicle cell phenotype, suppressible | partially by Act5CEP1604, Scer\GAL4slbo.2.6 Rac1N17.Scer\UAS, Scer\GAL4slbo.2.6 has border follicle cell phenotype, suppressible | partially by Ark[+]/ArkCD8 Rac1N17.Scer\UAS, Scer\GAL4slbo.2.6 has border follicle cell phenotype, suppressible | partially by ArkCD4/Ark[+] Rac1N17.Scer\UAS, Scer\GAL4slbo.2.6 has border follicle cell phenotype, suppressible | partially by ArkCD4/ArkCD4 Rac1N17.Scer\UAS, Scer\GAL4slbo.2.6 has border follicle cell phenotype, suppressible | partially by ArkCD4/ArkCD8 Rac1N17.Scer\UAS, Scer\GAL4slbo.2.6 has border follicle cell phenotype, suppressible | partially by ArkCD8/ArkCD8 Rac1N17.Scer\UAS, Scer\GAL4slbo.2.6 has border follicle cell phenotype, suppressible | partially by chicScer\UAS.cCa, Scer\GAL4slbo.2.6 Rac1N17.Scer\UAS, Scer\GAL4slbo.2.6 has border follicle cell phenotype, suppressible | partially by Iap2Scer\UAS.cWa, Scer\GAL4slbo.2.6 Rac1N17.Scer\UAS, Scer\GAL4slbo.2.6 has border follicle cell phenotype, suppressible | partially by NcCARD.Scer\UAS, Scer\GAL4slbo.2.6 Rac1N17.Scer\UAS, Scer\GAL4slbo.2.6 has border follicle cell phenotype, suppressible | partially by NcΔN.C-A.Scer\UAS, Scer\GAL4slbo.2.6 Rac1N17.Scer\UAS, Scer\GAL4slbo.2.6 has border follicle cell phenotype, suppressible | partially by thEP3279, Scer\GAL4slbo.2.6 Rac1N17.Scer\UAS, Scer\GAL4slbo.2.6 has border follicle cell phenotype, suppressible | partially by thEP3308, Scer\GAL4slbo.2.6 Rac1N17.Scer\UAS, Scer\GAL4slbo.2.6 has border follicle cell phenotype, suppressible | partially by thScer\UAS.T:Ivir\HA1, Scer\GAL4slbo.2.6 Rac1N17.Scer\UAS, Scer\GAL4slbo.2.6 has border follicle cell phenotype, suppressible | partially by trioScer\UAS.cBa, Scer\GAL4slbo.2.6 Rac1N17.Scer\UAS, Scer\GAL4slbo.2.6 has border follicle cell phenotype, suppressible by hopTum.Scer\UAS, Scer\GAL4slbo.2.6 Rac1N17.Scer\UAS, Scer\GAL4slbo.2.6 has border follicle cell phenotype, suppressible by osScer\UAS.cCa, Scer\GAL4slbo.2.6 Rac1N17.Scer\UAS, Scer\GAL4slbo.2.6 has border follicle cell phenotype, suppressible by Stat92EScer\UAS.cPa, Scer\GAL4slbo.2.6 Rac1N17.Scer\UAS, Scer\GAL4unspecified has embryonic epidermis | dorsal phenotype, suppressible by JraAsp.hs.sev | |||
NOT suppressed by | |||
Statement Reference Rac1N17.Scer\UAS, Scer\GAL4ato.3.6 has axon & dorsal cluster neuron phenotype, non-suppressible by btlScer\UAS.cDa, Scer\GAL4ato.3.6 Rac1N17.Scer\UAS, Scer\GAL4ato.3.6 has axon & dorsal cluster neuron phenotype, non-suppressible by dsh1 Rac1N17.Scer\UAS, Scer\GAL4elav.PLu has abdominal segmental nerve phenotype, non-suppressible by plexBBd7.Scer\UAS, Scer\GAL4elav.PLu Rac1N17.Scer\UAS, Scer\GAL4elav.PLu has intersegmental nerve phenotype, non-suppressible by plexBBd7.Scer\UAS, Scer\GAL4elav.PLu Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has eye phenotype, non-suppressible by Sra-1EP3267, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has eye phenotype, non-suppressible by Sra-1unspecified Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has ommatidium phenotype, non-suppressible by Sra-1EP3267, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF Rac1N17.Scer\UAS, Scer\GAL4GMR.PF/Scer\GAL4GMR.PF has ommatidium phenotype, non-suppressible by Sra-1unspecified Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has eye phenotype, non-suppressible by Akap200EP2072, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has eye phenotype, non-suppressible by CG2017EP3503, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has eye phenotype, non-suppressible by cindrEP3700, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has eye phenotype, non-suppressible by EP474EP474, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has eye phenotype, non-suppressible by hppyEP2445, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has eye phenotype, non-suppressible by MESR4EP386, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has eye phenotype, non-suppressible by P{EP}faxEP807, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has eye phenotype, non-suppressible by P{EP}wunEP652, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has eye phenotype, non-suppressible by rho-6EP2023, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has eye phenotype, non-suppressible by RhoGEF64CEP3035, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4GMR.PU has eye phenotype, non-suppressible by Traf6EP325, Scer\GAL4GMR.PU Rac1N17.Scer\UAS, Scer\GAL4how-24B/Scer\GAL4how-24B has myoblast phenotype, non-suppressible by thScer\UAS.T:Ivir\HA1, Scer\GAL4how-24B/Scer\GAL4how-24B Rac1N17.Scer\UAS, Scer\GAL4slbo.2.6 has border follicle cell phenotype, non-suppressible by awdScer\UAS.cDa, Scer\GAL4slbo.2.6 Rac1N17.Scer\UAS, Scer\GAL4slbo.2.6 has border follicle cell phenotype, non-suppressible by BacA\p35Scer\UAS.cHa, Scer\GAL4slbo.2.6 Rac1N17.Scer\UAS, Scer\GAL4slbo.2.6 has border follicle cell phenotype, non-suppressible by slboScer\UAS.cLa, Scer\GAL4slbo.2.6 Rac1N17.Scer\UAS has border follicle cell phenotype, non-suppressible by Mmus\Cd8aScer\UAS.T:Avic\GFP/Scer\GAL4slbo.2.6 | |||
Enhancer of | |||
Statement Reference Scer\GAL460/Rac1N17.Scer\UAS is an enhancer of intersegmental nerve | heat sensitive phenotype of Nl1N-ts1 Scer\GAL460/Rac1N17.Scer\UAS is an enhancer of intersegmental nerve branch ISNb of A1-7 | heat sensitive phenotype of Nl1N-ts1 | |||
NOT Enhancer of | |||
Statement Reference Rac1N17.Scer\UAS, Scer\GAL4477 is a non-enhancer of multidendritic neuron & dendrite | supernumerary phenotype of Scer\GAL4477, trcK122A.Scer\UAS.T:Zzzz\FLAG/trcK122A.Scer\UAS.T:Zzzz\FLAG Rac1N17.Scer\UAS, Scer\GAL4477 is a non-enhancer of multidendritic neuron & dendrite phenotype of Scer\GAL4477, trcK122A.Scer\UAS.T:Zzzz\FLAG/trcK122A.Scer\UAS.T:Zzzz\FLAG Rac1N17.Scer\UAS, Scer\GAL4ato.3.6 is a non-enhancer of axon & dorsal cluster neuron phenotype of Scer\GAL4ato.3.6, bskDN.Scer\UAS | |||
Suppressor of | |||
Statement Reference Rac1N17.Scer\UAS, Scer\GAL4477 is a suppressor of multidendritic neuron & dendrite | supernumerary phenotype of Scer\GAL4477, trcK122A.Scer\UAS.T:Zzzz\FLAG/trcK122A.Scer\UAS.T:Zzzz\FLAG Rac1N17.Scer\UAS, Scer\GAL4ato.3.6 is a suppressor of axon & dorsal cluster neuron phenotype of Scer\GAL4ato.3.6, btlScer\UAS.cDa Rac1N17.Scer\UAS, Scer\GAL4ftz.ng is a suppressor | partially of dMP2 neuron phenotype of Ggal\MLCKct.Scer\UAS, Scer\GAL4ftz.ng Rac1N17.Scer\UAS, Scer\GAL4ftz.ng is a suppressor | partially of pCC neuron phenotype of Ggal\MLCKct.Scer\UAS, Scer\GAL4ftz.ng Rac1N17.Scer\UAS, Scer\GAL4ftz.ng is a suppressor | partially of vMP2 neuron phenotype of Ggal\MLCKct.Scer\UAS, Scer\GAL4ftz.ng Rac1N17.Scer\UAS/Scer\GAL4elav.PLu is a suppressor of NMJ bouton phenotype of Vps35EY14200/Df(2R)ED3952 | |||
NOT Suppressor of | |||
Statement Reference Rac1N17.Scer\UAS, Scer\GAL4332.3 is a non-suppressor of amnioserosa phenotype of Scer\GAL4332.3, crbScer\UAS.cWa Rac1N17.Scer\UAS, Scer\GAL4477 is a non-suppressor of multidendritic neuron & dendrite | supernumerary phenotype of Scer\GAL4477, trcK122A.Scer\UAS.T:Zzzz\FLAG/trcK122A.Scer\UAS.T:Zzzz\FLAG Rac1N17.Scer\UAS, Scer\GAL4477 is a non-suppressor of multidendritic neuron & dendrite phenotype of Scer\GAL4477, trcK122A.Scer\UAS.T:Zzzz\FLAG/trcK122A.Scer\UAS.T:Zzzz\FLAG Rac1N17.Scer\UAS, Scer\GAL4ato.3.6 is a non-suppressor of axon & dorsal cluster neuron phenotype of Scer\GAL4ato.3.6, bskDN.Scer\UAS Scer\GAL4nos.UTR.T:Hsim\VP16/Rac1N17.Scer\UAS is a non-suppressor of germline cell | germline clone | maternal effect | embryonic stage 15 phenotype of wun2EP2650ex34, wun49 Scer\GAL4nos.UTR.T:Hsim\VP16/Rac1N17.Scer\UAS is a non-suppressor of germline cell | germline clone | maternal effect | embryonic stage 16 phenotype of wun2EP2650ex34, wun49 Scer\GAL4NP2225/Rac1N17.Scer\UAS is a non-suppressor of dendritic tree | embryonic stage phenotype of cv-c1260 Scer\GAL4NP2225/Rac1N17.Scer\UAS is a non-suppressor of dorsal multidendritic neuron ddaE | embryonic stage phenotype of cv-c1260 | |||
Other | |||
Statement Reference | |||
Additional Comments
| |||
Genetic Interactions
| |||
Statement Reference Animals expressing dominant-negative Rac1[N17.Scer\UAS] under the control of Scer\GAL4[sev.EP] display no discernible differences in the presence or absence of homozygous CRMP[supK1]. Overexpression of Rac1[N17.Scer\UAS] under the control of Scer\GAL4[15J2] suppresses the early longitudinal axon phenotype of N[l1N-ts1]. Expression of Rac1[N17.Scer\UAS] under the control of Scer\GAL4[60], significantly increases the occurrence of ISNb bypass in N[l1N-ts1] embryos. Co-expression of Rab11[S25N.Scer\UAS.P\T.T:Avic\GFP-YFP] with Rac1[N17.Scer\UAS] driven by Scer\GAL4[slbo.2.6] enhances the border follicle cell migration phenotype associated with Rac1[N17.Scer\UAS] expression. Co-expression of Rac1[N17.Scer\UAS] and Dcp-1[Scer\UAS.cKa] (insertion line P{UAS-Dcp-1.K}19-2) under the control of Scer\GAL4[GMR.PF] is lethal. Expression of Rac1[N17.Scer\UAS] in the germline under the control of Scer\GAL4[nos.UTR.T:Hsim\VP16] does not rescue the germ cell death seen in embryos derived from females carrying wun[49] wun2[EP2650ex34] germline clones. Expression of Rac1[N17.Scer\UAS] under the control of Scer\GAL4[NP2225] does not suppress the reduction in length of secondary dendritic branches which is seen in the ddaE neurons of cv-c[1260] embryos at 20-22 hours after egg laying. Expression of Rac1[N17.Scer\UAS] under the control of Scer\GAL4[twi.2PE] enhances the mesodermal migration defects seen in pbl[5] homozygotes. The Scer\GAL4[GMR.PU], Rac1[N17.Scer\UAS] rough eye phenotype is suppressed by co-expression of Ced-12[Scer\UAS.cGa] and mbc[Scer\UAS.cBa]. The increased bouton number at the neuromuscular junction that is seen in Vps35[EY14200]/Df(2R)ED3952 larvae is suppressed by expression of Rac1[N17.Scer\UAS] under the control of either Scer\GAL4[elav.PLu] or Scer\GAL4[C57]. The axonal hyperfasciculation phenotype in the lamina and medulla caused by expression of Rac1N17.Scer\UAS under the control of Scer\GAL4GMR.PF is enhanced by bure10/+. Coexpression of bskDN.Scer\UAS and Rac1N17.Scer\UAS under the control of Scer\GAL4ato.3.6 results in the few dorsal cluster neuron axons crossing the optic chiasma, which is the same phenotype seen as single bskDN.Scer\UAS expression and is opposite to that seen when only Rac1N17.Scer\UAS is expressed.
Coexpression of btlScer\UAS.cDa and Rac1N17.Scer\UAS, under the control of Scer\GAL4ato.3.6, results in the dominance of the Rac1N17.Scer\UAS phenotype, with a large increase in the number of dorsal cluster neuron axons that cross the optic chiasm.
Coexpression of btlDN.Scer\UAS and Rac1N17.Scer\UAS, under the control of Scer\GAL4ato.3.6, results in all dorsal cluster neuron axons crossing the optic chiasm, instead of the majority retracting and branching within the lobula.
Expression of Rac1N17.Scer\UAS, under the control of Scer\GAL4ato.3.6, in a dsh1 background results in a dorsal neuron cluster phenotype similar to when Rac1N17.Scer\UAS is expressed in a wild-type background, which is opposite to that seen in dsh1 mutants. When RhoGAP93BScer\UAS.cHa is added to RhoGAP93BScer\UAS.cHa, Scer\GAL4elav.PLu embryos, multiple axons exhibit ectopic crossing of the midline. On the other hand Cdc42N17.Scer\UAS does not enhance this phenotype. When RhoGAP93BScer\UAS.cHa is added to Rac1N17.Scer\UAS, Scer\GAL4elav.PLu embryos, multiple axons exhibit ectopic crossing of the midline. On the other hand Cdc42N17.Scer\UAS does not enhance this phenotype. Expression of osScer\UAS.cCa, hopTum.Scer\UAS or Stat92EScer\UAS.cPa suppress the border cell migration defect caused by expression of Rac1N17.Scer\UAS under the control of Scer\GAL4slbo.2.6. However, expression of awdScer\UAS.cDa does not suppress this phenotype. Co-expression of Cdc42N17.Scer\UAS and Rac1N17.Scer\UAS in the muscle, under the regulation of Scer\GAL4Mhc.PW has no effect on gross synapse development. The border follicle cell migration defect seen in egg chambers expressing Rac1N17.Scer\UAS under the control of Scer\GAL4slbo.2.6 is partially suppressed by coexpression of trioScer\UAS.cBa, Act5CEP1604, thEP3308, thEP3279, thScer\UAS.T:Ivir\HA1 or Iap2Scer\UAS.cWa. The penetrance of the embryonic lethal phenotype caused by expression of Rac1N17.Scer\UAS under the control of Scer\GAL469B or Scer\GAL4pnr-MD237 is reduced by coexpression of thScer\UAS.T:Ivir\HA1. The embryonic cuticle phenotype (dorsal hole) caused by expression of Rac1N17.Scer\UAS under the control of Scer\GAL469B or Scer\GAL4pnr-MD237 is rescued by coexpression of thScer\UAS.T:Ivir\HA1. The dramatic defects in myoblast fusion caused by expression of Rac1N17.Scer\UAS under the control of Scer\GAL4how-24B are not rescued by coexpression of thScer\UAS.T:Ivir\HA1. The border follicle cell migration defect seen in egg chambers expressing Rac1N17.Scer\UAS under the control of Scer\GAL4slbo.2.6 is partially suppressed by coexpression of chicScer\UAS.cCa. The border follicle cell migration defect seen in egg chambers expressing Rac1N17.Scer\UAS under the control of Scer\GAL4slbo.2.6 is partially suppressed by coexpression of NcΔN.C-A.Scer\UAS or NcCARD.Scer\UAS. The border follicle cell migration defect seen in egg chambers expressing Rac1N17.Scer\UAS under the control of Scer\GAL4slbo.2.6 is partially suppressed by ArkCD4/+, ArkCD8/+, ArkCD4/ArkCD4, ArkCD8/ArkCD8 or ArkCD4/ArkCD8. The border follicle cell migration defect seen in egg chambers expressing Rac1N17.Scer\UAS under the control of Scer\GAL4slbo.2.6 is not suppressed by coexpression of slboScer\UAS.cLa. The combination of heterozygous sli2 and pan-neural overexpression of Rac1N17.Scer\UAS (expressed under the control of Scer\GAL4elav.PLu) leads to longitudinal axon ectopic midline crossing defects. An average of 8.3 defects are seen per animal, and an average of 75% of segments have defects. If expression of Rac1N17.Scer\UAS is driven by Scer\GAL4ftz.ng 4 defects are seen per animal, and an average of 36% of segments have defects. Co-expression of PakScer\UAS.T:Myr1 partially suppresses longitudinal axon ectopic midline crossing defects seen in sli2/+, Rac1N17.Scer\UAS ; Scer\GAL4elav.PLu animals. An average of 5 defects are seen per animal, and an average of 45% of segments have defects. The addition of Rac1N17.Scer\UAS (driven by Scer\GAL4ftz.ng) to robo1/+ embryos has no effect on the midline crossover phenotype seen in the pCC/MP2 pathway axons. The addition of Rac1N17.Scer\UAS (driven by Scer\GAL4ftz.ng) to Sose49 homozygous embryos enhances the midline crossover phenotype seen in the pCC/MP2 pathway axons. 91% of embryos exhibit the phenotype. An average of 8.0 crossovers are seen per embryo. The addition of chicsand-1 to Rac1N17.Scer\UAS has no effect on their midline crossover phenotypes in the pCC/MP2 pathway axons. Embryos that express both crbScer\UAS.cWa and Rac1N17.Scer\UAS driven by Scer\GAL4332.3 show the premature apical cell constriction phenotype in the amnioserosa that is seen when crbScer\UAS.cWa expression alone is driven by Scer\GAL4332.3. The addition of plexBScer\UAS.cHa to Rac1N17.Scer\UAS, Scer\GAL4elav.PLu flies enhances the ISNb bypass phenotype seen in these flies. The addition of plexBScer\UAS.cHa to Rac1N17.Scer\UAS, Scer\GAL4elav.PLu flies has no effect on the ISNb bypass phenotype seen in these flies. The addition of plexBScer\UAS.cHa to Rac1N17.Scer\UAS, Scer\GAL4elav.PLu flies significantly suppresses the ISNb bypass phenotype seen in these flies. The addition of Rho1k07903 to Rac1N17.Scer\UAS,Scer\GAL4hs.2sev flies significantly enhances the eye phenotype. There is an increase in the number of achiral ommatidia. tkvTAJ3 partially rescues the dorsal closure defect caused by expression of Rac1N17.Scer\UAS under the control of Scer\GAL4hs.PB. The Rac1N17.Scer\UAS dorsal open phenotype can be significantly rescued by heat induced expression of JraAsp.hs.sev. | |||
Xenogenetic Interactions
| |||
Statement Reference Border cell clusters expressing Rac1[N17.Scer\UAS] and Hsap\RAC1[PA.Q61L.Scer\UAS.T:Disc\RFP-mCherry,T:Zzzz\PT1] under the control of Scer\GAL4[slbo.2.6] in which Hsap\RAC1[PA.Q61L.Scer\UAS.T:Disc\RFP-mCherry,T:Zzzz\PT1] has been activated by illumination in one cell do not show forward migration. However, photoactivation of Hsap\RAC1[PA.Q61L.Scer\UAS.T:Disc\RFP-mCherry,T:Zzzz\PT1] in approximately half of the cluster results in slow forward movement. The border follicle cell migration defect seen in egg chambers expressing Rac1N17.Scer\UAS under the control of Scer\GAL4slbo.2.6 is not suppressed by coexpression of Mmus\Cd8aScer\UAS.T:Avic\GFP. The border follicle cell migration defect seen in egg chambers expressing Rac1N17.Scer\UAS under the control of Scer\GAL4slbo.2.6 is not significantly suppressed by coexpression of BacA\p35Scer\UAS.cHa. The addition of Rac1N17.Scer\UAS to Ggal\MLCKct.Scer\UAS, Scer\GAL4ftz.ng embryos partially suppresses the midline crossover phenotype seen in the pCC/MP2 pathway axons. 4.0% of embryos exhibit the phenotype. An average of 1.o crossovers are seen per embryo. | |||
Complementation & Rescue Data
| |||
| Partially rescued by | |||
| Comments | The border follicle cell migration defect seen in egg chambers expressing Rac1N17.Scer\UAS under the control of Scer\GAL4slbo.2.6 is partially suppressed by coexpression of Rac1Scer\UAS.cLa. | ||
Stocks
( 2 ) | |||
| Bloomington | |||
| Kyoto | 108725 | ||
Notes on Origin
| |||
| Discoverer | |||
External Crossreferences & Linkouts
| |||
| Other Crossreferences | |||
| Linkouts | |||
Synonyms & Secondary IDs
( 9 ) | |||
| Reported As | |||
| Symbol Synonym | DRac1N17 Drac1N17 DracDN DRacN17 Rac1.N17 Rac1N17.Scer\UAS Rac1N17.UAS Rac1N17 | ||
| Name Synonym | |||
| Secondary FlyBase IDs | |||
| |||
References
( 84 ) | |||
| Generate a list of | |||
| List References by type |
| ||
Recent research papers ( 6 ) | |||
| |||
Recent reviews (0)
| |||
| All reviews listed in FlyBase were published before 2011 | |||
Recent Updates
External Crossreferences & Linkouts